Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Comment by BudFoxx2020on Dec 29, 2020 10:32am
160 Views
Post# 32190899

RE:RE:RE:The merger

RE:RE:RE:The mergerGreat post Thegrapeone.  This deal absolutely stinks, I even explained why and said it will drop to $8.  The clueless kids in here keep pumping that this is great for the long term, APHA will be the biggest player, blah, blah, blah.  That is not a given, there is too many unkown factors that can happen.  Tilray was a company that was failing bad, there is absolutely no benefit in this deal for APHA at all.  This is not an argument, this is a fact.  Look at APHA sp now, the markets knows and the markets never lies and APHA shareholders are gettting shafted again.  This deal should not have happened, the only reason for it and I already posted it is, Management probably got offered a huge incentive to make it happen so Privateer and Tilray insiders can bail on the back of APHA shareholders.  If earnings even miss expection by a little, there will be more pain coming for APHA shareholders.  And on top of that if Tilray earnnigs stinks, which it will, its a double whammy for APHA.   I am not here to bash just poiting my opinion.  Better hope everything goes well on Jan 6, otherwise.....  Good luck.
<< Previous
Bullboard Posts
Next >>

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse